促銷說明書和廣告中產(chǎn)品名稱的顯示，對(duì)正確識(shí)別藥品和確保其安全有效的使用有重要作用。美國(guó)食品藥品管理局（FDA）于2017年12月發(fā)布了“在促銷說明書和廣告中產(chǎn)品名稱位置、大小和突出程度的供企業(yè)用的指導(dǎo)原則”。詳細(xì)介紹該指導(dǎo)原則，以期對(duì)我國(guó)各種媒體的藥品宣傳資料和廣告的發(fā)布和監(jiān)管有所幫助。

The product name of drugs in promotional labeling and advertisements is important for proper identification of medicine to ensure the safety and effective use. FDA announced product name placement, size, and prominence in promotional labeling and advertisements guidance for industry in December 2017. This paper introduces the main content of the guideline. It is expected to be helpful for the release and supervision of drug publicity materials and advertisements in various media of China.